Disc up another 5.4% last night on impressive volume to a market cap of $2.5 Billion AUD. That is more than three times the valuation of CUV. CUV has the FDA, EMA drug and the absolute monopoly on EPP and great cash and profits with a Phase 3 into blockbuster Vitiligo. Loss making Disc just hoping to one day in many years to achieve approval in EPP and enter that market. I think it's fair to say shorters have had a big impact here at CUV as ASIC daily data shows and some effort needs to be made to protect shareholder interests right now via a share buyback. Disc is also so much better at attracting investor interest than at CUV and they need to lift their game a lot in that area - after all the newsletter stated it only took one institution buying a lot of shares in one month to take the CUV price over $40.
All IMO DYOR
- Forums
- ASX - By Stock
- CUV
- Disc Medicine - Best comparison stock to Clinuvel
Disc Medicine - Best comparison stock to Clinuvel, page-16
-
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.17 |
Change
0.080(0.57%) |
Mkt cap ! $709.3M |
Open | High | Low | Value | Volume |
$14.02 | $14.28 | $13.94 | $860.1K | 60.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 685 | $14.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.20 | 3 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 685 | 14.160 |
1 | 355 | 14.110 |
1 | 355 | 14.090 |
1 | 355 | 14.070 |
1 | 355 | 14.050 |
Price($) | Vol. | No. |
---|---|---|
14.200 | 3 | 1 |
14.240 | 355 | 1 |
14.260 | 355 | 1 |
14.280 | 1188 | 2 |
14.290 | 1440 | 1 |
Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |